505 results
Page 4 of 26
8-K
EX-99.1
2jkcw
21 Dec 20
Ligand and GSK Enter Global Collaboration and License Agreement Leveraging Icagen’s Discovery Technology to Target Neurological Disorders
8:39am
8-K/A
EX-99.1
3491o7m8
10 Dec 20
Financial Statements and Exhibits
4:13pm
8-K
EX-99.1
4j71ri6tpjbo 3y
30 Oct 20
Ligand Reports Third Quarter 2020 Financial Results
8:03am
8-K
EX-99.1
0has23 9v2
20 Oct 20
Results of Operations and Financial Condition
10:52am
8-K
EX-2.1
aps2ma0q4nd
13 Oct 20
Entry into a Material Definitive Agreement
8:44am
8-K
EX-99.1
aoqd cs5kl
1 Oct 20
Contingent Value Rights Agreement
8:42am
8-K
EX-10.1
yqn5jaauh askdu8i
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-10.2
zb9s 1rz6re
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-10.3
zcl3f2v0
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
SC TO-T
EX-99
kcmg5a3vts
31 Aug 20
Third party tender offer statement
8:46am
SC TO-T
EX-99
vj0d22ci
31 Aug 20
Third party tender offer statement
8:46am
SC TO-T
EX-99
b81xx
31 Aug 20
Third party tender offer statement
8:46am
SC TO-C
EX-99.1
hjd f4ewmf6jx67qzgs
10 Aug 20
Information about tender offer
9:52pm
SC TO-C
EX-2.1
3pg7n
10 Aug 20
Information about tender offer
9:50pm
SC TO-C
EX-99.1
2xeer4
10 Aug 20
Information about tender offer
9:50pm
SC TO-C
EX-99.2
bnrt29 dq5e
10 Aug 20
Information about tender offer
9:50pm